Division of Neuroscience, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milano, Italy.
Neurobiol Dis. 2010 Jan;37(1):77-85. doi: 10.1016/j.nbd.2009.09.009. Epub 2009 Sep 23.
Neuroferritinopathies are dominantly inherited movement disorders associated with nucleotide insertions in the L-ferritin gene that modify the protein's C-terminus. The insertions alter physical and functional properties of the ferritins, causing an imbalance in brain iron homeostasis. We describe the effects produced by the over-expression in HeLa and neuroblastoma SH-SY5Y cells of two pathogenic L-ferritin variants, 460InsA and 498InsTC. Both peptides co-assembled with endogenous ferritins, producing molecules with reduced iron incorporation capacity, acting in a dominant negative manner. The cells showed an increase in cell death and a decrease in proteasomal activity. The formation of iron-ferritin aggregates became evident after 10 days of variant expression and was not associated with increased cell death. The addition of iron chelators or antioxidants restored proteasomal activity and reduced aggregate formation. The data indicate that cellular iron imbalance and oxidative damage are primary causes of cell death, while aggregate formation is a secondary effect.
神经铁蛋白病是一种显性遗传性运动障碍,与 L 铁蛋白基因中的核苷酸插入有关,这些插入改变了蛋白质的 C 末端。这些插入改变了铁蛋白的物理和功能特性,导致大脑铁平衡失调。我们描述了在 HeLa 和神经母细胞瘤 SH-SY5Y 细胞中过度表达两种致病 L 铁蛋白变体 460InsA 和 498InsTC 产生的影响。这两种肽都与内源性铁蛋白共组装,产生铁结合能力降低的分子,以显性负性方式发挥作用。细胞死亡增加,蛋白酶体活性降低。变体表达 10 天后,明显形成铁铁蛋白聚集体,但与细胞死亡增加无关。添加铁螯合剂或抗氧化剂可恢复蛋白酶体活性并减少聚集体形成。数据表明,细胞内铁失衡和氧化损伤是细胞死亡的主要原因,而聚集体形成是次要效应。